+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Healthcare Expenditure and Pharmaceutical Sales by Region, Patent Expiries, New Technologies and Mergers and Acquisitions - Overview of 2022 and Outlook for 2023

  • PDF Icon


  • 56 Pages
  • January 2023
  • Region: Global
  • GlobalData
  • ID: 5744885
The publisher is pleased to present an executive summary of healthcare expenditure and pharmaceutical sales forecasts from its Q1 2023 forecast cycle.

Global 10-year outlook for healthcare spend and pharmaceutical sales from the publisher's unique forecasting model. Provides key drivers and risks to outlook and includes the 2023 annual report summarizing our outlook for the year ahead.

Key Highlights

The Covid-19 pandemic, the Russia-Ukraine war, rising domestic debts, higher inflation, and tighter monetary policy have converged to weaken the global economy. Going forward, we see additional risks emanating from geopolitical tensions in Asia and the Middle East, which could plunge the global economy into a deeper recession.

Global economic growth is projected to stay at 1.7% in 2023.

Global healthcare spending is projected to grow 5.1% to $10.2 trillion in 2023, and 5.2% in 2024.

Global pharmaceutical sales are projected to grow 4.2% to $1.5 trillion in 2023 and 4.3% in 2024, driven by new product entries, and continued spending on COVID-19 vaccines and therapeutics.


  • The forecasts summarised here include healthcare spending, pharmaceutical sales, and several other indicators across 70 markets
  • In this executive summary, the publisher examines the trends in healthcare spending and pharma sales for
  • five key groups of markets: the US, the top five European markets (France, Germany, Italy, Spain, and
  • the UK), Japan, BRIC-MT (Brazil, Russia, India, China, Mexico, and Turkey), and the Secondary emerging
  • markets (Colombia, Indonesia, Malaysia, Nigeria, the Philippines, Poland, Saudi Arabia, South Africa,
  • Thailand, and Vietnam)

Reasons to Buy

This report will enhance your decision-making capability by allowing you to:

  • Develop business strategies by understanding the trends shaping and driving the Australian healthcare market
  • Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact the Australian healthcare market in the future
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors' performance
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership

Table of Contents

  • P&R 2022 Round Up, 2023 Outlook
  • Executive Summary
  • Regional Overview
  • MARS first - quarter update
  • Regional Overview and country focus
  • Americas
  • Europe
  • Asia and other regions
  • Changes to MARS
  • Selected positive events
  • Selected negative events
  • Appendix: MARS methodology